What are the benefits? Risks? And are you protected?
It's become a cautionary tale for biotech investors. Are they heeding it?
Wall Street Journal investigative reporter John Carreyrou discovered that all wasn't as it appeared at Theranos, the biotech company founded by Elizabeth Holmes.
The settlement comes two years after the SEC began looking into claims at Theranos that it had developed potentially revolutionary blood-testing technology.
The blood-testing startup has been plagued with problems.
The Wall Street Journal reports tens of thousands of corrections were issued.